Clinical Trials on Recurrent Ovarian Epithelial Cancer in Australia
Total 455 results
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Medical University InnsbruckRecruitingRecurrent Ovarian CarcinomaAustria
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
Krankenhaus Barmherzige Schwestern LinzWithdrawnFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustria
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of QueenslandCompletedOvarian Cancer Stage IV | Ovarian Cancer Stage IIIAustralia
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Cancer Australia Priority-driven Collaborative...CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustralia
-
National University Hospital, SingaporeKK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...UnknownOvarian Cancer | Fallopian Tube CancerSingapore, Australia
-
PharmAbcineActive, not recruitingRecurrent GlioblastomaAustralia
-
Neovii BiotechCompletedOvarian Cancer | Epithelial Ovarian CancerAustria, Germany
-
Paul Speiser, Prof.MD,CompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Czechia, Germany, Ireland
-
Prima BioMed LtdCompletedEpithelial Ovarian CancerUnited States, Australia
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
Prima BioMed LtdCompleted
-
Prima BioMed LtdTerminatedEpithelial Ovarian CancerUnited States, Australia
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Anthony Joshua, FRACPSt Vincent's Hospital, Sydney; Royal Prince Alfred Hospital, Sydney, Australia and other collaboratorsRecruitingOvarian CancerAustralia
-
Walter and Eliza Hall Institute of Medical ResearchJohns Hopkins UniversityActive, not recruitingOvarian CancerAustralia, United States
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
Exscientia GmbHAGO Research GmbHRecruitingEpithelial Ovarian CancerAustria, Germany
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Hoffmann-La RocheCompletedOvarian Cancer, Peritoneal NeoplasmsAustria
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaAustralia
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
AmgenActive, not recruitingNon-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid TumorsUnited States, Australia, Switzerland
-
PharmAbcineTerminatedRecurrent GlioblastomaAustralia, United States
-
Australian & New Zealand Children's Haematology...The Hospital for Sick Children; Kazia Therapeutics Limited; Day One Biopharmaceuticals... and other collaboratorsNot yet recruitingChildhood Cancer | Refractory Cancer | Recurrent Cancer | Childhood Solid Tumor | Childhood Brain TumorAustralia, Canada
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bosnia and Herzegovina, Bulgaria, Georgia, Korea, Republic of, Serbia
-
Angle plcMedical University of Vienna; Charite University, Berlin, Germany; Vivantes Netzwerk...CompletedEvaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.Ovarian NeoplasmsGermany, Austria
-
EBMT Solid Tumors Working PartyCompletedOvarian CancerSwitzerland, Spain, United Kingdom, Italy, Slovakia, Germany, Belgium, Austria, Czech Republic
-
Nektar TherapeuticsMerck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States, Austria, Greece, Italy
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Grade III Glioma | Grade III GliomaUnited States, Australia, Israel, Switzerland
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
Canadian Cancer Trials GroupApotex Inc.Active, not recruiting
-
Medical University InnsbruckRoche, AustriaUnknownRecurrent Malignant GliomaAustria
-
Eli Lilly and CompanyCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Germany, Belgium
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland